Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 568

  • The following terms were not found in PubMed: 10.3389, .2019.00683.
  • Showing results for 10.3389/micb .2019.00683. Your search for 10.3389/fmicb.2019.00683 retrieved no results.
1.

Varicose veins of lower extremities: Insights from the first large-scale genetic study.

Shadrina AS, Sharapov SZ, Shashkova TI, Tsepilov YA.

PLoS Genet. 2019 Apr 18;15(4):e1008110. doi: 10.1371/journal.pgen.1008110. [Epub ahead of print]

PMID:
30998689
2.

Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells.

Bhat J, Dubin S, Dananberg A, Quabius ES, Fritsch J, Dowds CM, Saxena A, Chitadze G, Lettau M, Kabelitz D.

Front Immunol. 2019 Mar 27;10:569. doi: 10.3389/fimmu.2019.00569. eCollection 2019.

3.

Visualization and quantification of NK cell-mediated cytotoxicity over extended time periods by image cytometry.

Chan LL, Wucherpfennig KW, de Andrade LF.

J Immunol Methods. 2019 Apr 2. pii: S0022-1759(19)30012-2. doi: 10.1016/j.jim.2019.04.001. [Epub ahead of print]

PMID:
30951701
4.

Expression profile and prognostic value of SFN in human ovarian cancer.

Hu Y, Zeng Q, Li C, Xie Y.

Biosci Rep. 2019 Mar 29. pii: BSR20190100. doi: 10.1042/BSR20190100. [Epub ahead of print]

PMID:
30926680
5.

Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells.

Trinh TL, Kandell WM, Donatelli SS, Tu N, Tejera MM, Gilvary DL, Eksioglu EA, Burnette A, Adams WA, Liu J, Teer JK, Djeu JY, Coppola D, Wei S.

Oncoimmunology. 2019 Jan 17;8(4):e1557372. doi: 10.1080/2162402X.2018.1557372. eCollection 2019.

6.

Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.

Courau T, Bonnereau J, Chicoteau J, Bottois H, Remark R, Assante Miranda L, Toubert A, Blery M, Aparicio T, Allez M, Le Bourhis L.

J Immunother Cancer. 2019 Mar 14;7(1):74. doi: 10.1186/s40425-019-0553-9.

7.
8.

In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates

Karamanlıoğlu D, Dizbay M.

Turk J Med Sci. 2019 Apr 18;49(2):683-686. doi: 10.3906/sag-1808-55.

PMID:
30866602
9.

Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells.

Friedman J, Padget M, Lee J, Schlom J, Hodge J, Allen C.

Oral Oncol. 2019 Mar;90:38-44. doi: 10.1016/j.oraloncology.2019.01.017. Epub 2019 Feb 1.

PMID:
30846174
10.

In vitro Effects of Antimicrobial Agents on Planktonic and Biofilm Forms of Staphylococcus saprophyticus Isolated From Patients With Urinary Tract Infections.

Martins KB, Ferreira AM, Pereira VC, Pinheiro L, de Oliveira A, da Cunha MLRS.

Front Microbiol. 2019 Jan 28;10:40. doi: 10.3389/fmicb.2019.00040. eCollection 2019.

11.

Landscape of B cell immunity and related immune evasion in human cancers.

Hu X, Zhang J, Wang J, Fu J, Li T, Zheng X, Wang B, Gu S, Jiang P, Fan J, Ying X, Zhang J, Carroll MC, Wucherpfennig KW, Hacohen N, Zhang F, Zhang P, Liu JS, Li B, Liu XS.

Nat Genet. 2019 Mar;51(3):560-567. doi: 10.1038/s41588-018-0339-x. Epub 2019 Feb 11.

PMID:
30742113
12.

Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells.

Luna JI, Grossenbacher SK, Sturgill IR, Ames E, Judge SJ, Bouzid LA, Darrow MA, Murphy WJ, Canter RJ.

Cancers (Basel). 2019 Jan 14;11(1). pii: E85. doi: 10.3390/cancers11010085.

13.

Characterization of a novel MICB variant in an individual from the Chinese Uyghur population, MICB*005:09, by cloning and sequencing.

Tursun M, Wang Z, Guo W, Hasim A, Tian W.

Int J Immunogenet. 2019 Feb;46(1):17-19. doi: 10.1111/iji.12410. Epub 2018 Dec 18.

PMID:
30561160
14.

Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis.

Raam L, Kaleviste E, Šunina M, Vaher H, Saare M, Prans E, Pihlap M, Abram K, Karelson M, Peterson P, Rebane A, Kisand K, Kingo K.

Front Immunol. 2018 Nov 20;9:2707. doi: 10.3389/fimmu.2018.02707. eCollection 2018.

15.

Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.

Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13045-13050. doi: 10.1073/pnas.1808850115. Epub 2018 Nov 29.

PMID:
30498034
16.

MG132 selectively upregulates MICB through the DNA damage response pathway in A549 cells.

Luo D, Dong XW, Yan B, Liu M, Xue TH, Liu H, You JH, Li F, Wang ZL, Chen ZN.

Mol Med Rep. 2019 Jan;19(1):213-220. doi: 10.3892/mmr.2018.9676. Epub 2018 Nov 20.

17.

Diversity and characterisation of polymorphic 3' untranslated region haplotypes of MICA and MICB genes.

Cox ST, Hernandez D, Danby R, Turner TR, Madrigal JA.

HLA. 2018 Dec;92(6):392-402. doi: 10.1111/tan.13434.

PMID:
30471210
18.

Natural killer cell-based immunotherapy: a new fighter against melanoma?

Urbonas V, Smailyte G, Urbonaite GV, Dulskas A, Burokiene N, Kasiulevicius V.

Melanoma Res. 2019 Apr;29(2):208-211. doi: 10.1097/CMR.0000000000000552.

PMID:
30451786
19.

Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.

Liu BY, He XY, Zhuo RX, Cheng SX.

Nanoscale. 2018 Dec 7;10(45):21209-21218. doi: 10.1039/c8nr07321j. Epub 2018 Nov 12.

PMID:
30417194
20.

Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors.

Liu BY, He XY, Zhuo RX, Cheng SX.

J Control Release. 2018 Dec 10;291:90-98. doi: 10.1016/j.jconrel.2018.10.018. Epub 2018 Oct 16.

PMID:
30339905

Supplemental Content

Loading ...
Support Center